11
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2342 |
Raxatrigine
CNV1014802,CNV 1014802,GSK-1014802,CNV-1014802 |
Sodium Channel | Membrane transporter/Ion channel |
Raxatrigine (CNV 1014802) 是有效的钠离子通道 Nav1.7抑制剂。 | |||
T41192 |
CNV Dopamine
|
Others | Others |
CNV Dopamine is a carboxynitroveratryl (CNV)-caged dopamine; releases dopamine upon ultraviolet light stimulation (365 nm). Induces dopaminergic currents upon photolysis in brain slices expressing wild-type or GFP-labeled D2receptors. Displays no decrease in current (rundown) with UV light flash duration of up to 100 ms. Pharmacologically inactive prior to photolysis. | |||
T71239 |
CNV-2197944
|
Others | Others |
CNV-2197944 is a novel, small molecule, state-dependent calcium channel blocker, designed to selectively inhibit highly active Cav2.2 channels. | |||
T71237 |
SC 46944
|
Others | Others |
SC 46944 is a highly potent human renin inhibitor. | |||
T2141 |
Mecamylamine hydrochloride
盐酸美加明,Inversine,Mevasin |
AChR | Neuroscience |
Mecamylamine hydrochloride (Mevasin) 是一种易穿过血脑屏障的烟碱拮抗剂,用作高血压的神经节阻滞剂,具有抗神经疾病作用。 | |||
T14992 |
Raxatrigine hydrochloride
GSK-1014802 hydrochloride,CNV1014802 (hydrochloride) |
Others | Others |
Raxatrigine hydrochloride is a state-dependent sodium channel blocker and a Nav1.7 sodium channel inhibitor. | |||
T80459 |
ω-Conotoxin CnVIIA
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
ω-Conotoxin CnVIIA为含27个氨基酸的神经肽类毒素,具有N型钙电流阻滞活性。 | |||
T67746 |
IMS2186
|
Others | Others |
IMS2186 是一种抗脉络膜新生血管 (CNV) 试剂, 可以使癌细胞周期阻滞在 G2/M 期,由此产生抗增殖和抗血管生成作用。IMS2186 能够减少眼睛渗漏和病变细胞的数量,并且无眼内毒性。 | |||
T75156 |
Bevasiranib
|
Others | Others |
Bevasiranib 是一种siRNA,可沉默产生血管内皮生长因子(VEGF)的基因。VEGF 在脉络膜新生血管形成(choroidal neo-vascularization, CNV)的发病机制中起着关键作用,而CNV 是湿性年龄相关性黄斑变性(wet age-related macular degeneration, wet AMD)的前兆。 | |||
T75156L |
Bevasiranib sodium
|
Others | Others |
Bevasiranib sodium 是一种siRNA,可沉默产生血管内皮生长因子(VEGF)的基因。VEGF 在脉络膜新生血管形成(choroidal neo-vascularization, CNV)的发病机制中起着关键作用,而CNV 是湿性年龄相关性黄斑变性(wet age-related macular degeneration, wet AMD)的前兆。 | |||
T70329 |
SH-11037
|
Others | Others |
SH-11037 is a novel potent seh inhibitor, effectively blocking key angiogenic properties of human retinal endothelial cells (hrecs), inhibiting choroidal sprouting and significantly suppressing cnv lesion volume |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04722 |
DcR1/TRAILR3 Protein, Human, Recombinant (His)
TRAILR3,TRID,DCR1,TRAIL-R3,CD263,DCR1-TNFR,tumor necrosis fa... |
Human | HEK293 Cells |
TNFRSF10C CNV in patients with CRC is associated with distant metastatic disease. A high frequency of CGI methylation in the TNFRSF10C promoter results in inactivation of the gene and enhancement of tumor growth in most PC cell lines (except CFPAC-1). Inactivation of TNFRSF10C by CpG island (CGI) hypermethylation can play an important role in PC progression and be potentially useful as a diagnostic marker and a new therapeutic approach for PC. | |||
TMPK-00893 |
PGF Protein, Human, Recombinant (hFc)
PlGF,SHGC-10760,PGFL,PGF,D12S1900,PlGF-2 |
Human | HEK293 Cells |
Placental growth factor (PGF) is another member of the VEGF family of cytokines with pro-angiogenic and pro-inflammatory effects. Retinal inhibition of PGF in combination with VEGF-A prevents vascular leakage and CNV possibly via modulating their own expression in mononuclear phagocytes. PGF-related, optimized strategies to target inflammation-mediated angiogenesis may help to increase efficacy and reduce non-responders in the treatment of wet AMD patients. |